Our assets

  • A unique technology to chemically synthesize peptides and proteins >50 mer ( Most recent achievement: IL-10 (160 mer)).    
  • A GMP certified production site.    
  • 2,500 sqm building with room for expansion and dedicated production units.    
  • Production for all stages of development, from sequence to API commercial needs.    
  • Development of several vaccine candidates with large biotechs and big pharmas ( Ex: MSP3 (96 mer) for Institut Pasteur).